Injection technology for H2-mediated production of methane (InjectMe)
InjectMe develops a biological Power-to-Methane technology that uses electricity and CO2 from biogas to produce biomethane (electrofuel). The aim of InjectMe is to develop a cost-efficient system for biogas methanation in pilot-scale and evaluate its application as stand-alone system or coupled to other power-to-X technologies.
InjectMe will develop a biological methanation system for the conversion of electricity and biogas to natural gas-grade methane. By producing the methane from renewable electricity and CO2 from raw biogas, the resulting electrofuel combines features of both energy storage and CO2 capture.
The Power-to-Methane conversion technology of InjectMe uses Landia-based injector technology with the aim of reducing the production cost of methane via the Power-to-Methane process by using reactor capacity and biology already in place at biogas plants. The technical work will be done in pilot-scale to establish the InjectMe technology’s: (1) methane production capacity; (2) flexibility to enable operation at periods with low electricity prices; and (3) cost-efficiency to advance the production of renewable fuels through Power-to-X conversion. As part of (3), InjectMe will analyze the technical and commercial value of coupling the InjectMe technology to downstream Power-to-X technologies, including (1) chemical methanation, (2) biological methanation, (3) chemical power-to-methanol, and (4) the use of the InjectMe system as a stand-alone solution. InjectMe will in this way both develop new technology and provide a platform for choosing future coupling and development of the best possible Power-to-X systems.
Key figures
Category
Participants
Partner | Subsidy | Auto financing |
---|---|---|
Landia A/S | 2,27 mio. DKK | 2,27 mio. DKK |
Aarhus Universitet | 6,07 mio. DKK | 0,67 mio. DKK |
University of Queensland | 0,78 mio. DKK | 0,09 mio. DKK |
Contact
Industrivej 2, 6940 Lem St.
+45 97 34 12 44
www.landia.dk